TransUnion (NYSE:TRU) Stock Rating Upgraded by Wall Street Zen
by Doug Wharley · The Cerbat GemTransUnion (NYSE:TRU – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday.
TRU has been the subject of a number of other reports. Needham & Company LLC increased their price target on TransUnion from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Wednesday, July 29th. Morgan Stanley reissued an “overweight” rating and issued a $106.00 price objective on shares of TransUnion in a research note on Wednesday, July 29th. Bank of America cut their target price on TransUnion from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 19th. Barclays raised their target price on TransUnion from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 29th. Finally, UBS Group lifted their target price on TransUnion from $72.00 to $77.00 and gave the stock a “neutral” rating in a report on Thursday, July 2nd. Ten research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $94.38.
Read Our Latest Analysis on TRU
TransUnion Stock Up 0.0%
Shares of NYSE TRU opened at $85.68 on Friday. The company’s 50 day moving average price is $78.18 and its 200-day moving average price is $73.77. The company has a debt-to-equity ratio of 1.07, a quick ratio of 1.90 and a current ratio of 1.90. TransUnion has a 52-week low of $63.37 and a 52-week high of $95.50. The company has a market capitalization of $16.42 billion, a P/E ratio of 22.61, a price-to-earnings-growth ratio of 1.41 and a beta of 1.53.
TransUnion (NYSE:TRU – Get Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The business services provider reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.16 by $0.07. The company had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.28 billion. TransUnion had a net margin of 15.08% and a return on equity of 16.29%. TransUnion’s revenue for the quarter was up 14.9% compared to the same quarter last year. During the same period in the prior year, the company posted $1.08 earnings per share. TransUnion has set its Q3 2026 guidance at 1.180-1.210 EPS and its FY 2026 guidance at 4.750-4.830 EPS. Equities analysts forecast that TransUnion will post 4.24 earnings per share for the current year.
Insider Buying and Selling at TransUnion
In other TransUnion news, EVP Mohamed Abdelsadek sold 23,495 shares of the firm’s stock in a transaction that occurred on Tuesday, July 28th. The stock was sold at an average price of $85.00, for a total value of $1,997,075.00. Following the completion of the sale, the executive vice president owned 57,182 shares of the company’s stock, valued at approximately $4,860,470. This trade represents a 29.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Alicia Brooke Zuiker sold 8,673 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $78.49, for a total value of $680,743.77. Following the sale, the executive vice president owned 41,883 shares of the company’s stock, valued at approximately $3,287,396.67. This represents a 17.16% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 46,090 shares of company stock worth $3,710,541 in the last quarter. Company insiders own 0.37% of the company’s stock.
Hedge Funds Weigh In On TransUnion
Large investors have recently modified their holdings of the company. Geneos Wealth Management Inc. raised its holdings in TransUnion by 1,318.2% during the first quarter. Geneos Wealth Management Inc. now owns 312 shares of the business services provider’s stock worth $26,000 after buying an additional 290 shares during the last quarter. Cornerstone Planning Group LLC grew its holdings in shares of TransUnion by 130.2% during the fourth quarter. Cornerstone Planning Group LLC now owns 389 shares of the business services provider’s stock valued at $32,000 after buying an additional 220 shares during the last quarter. Measured Wealth Private Client Group LLC acquired a new position in shares of TransUnion during the third quarter valued at about $36,000. Essential Partners LLC increased its position in shares of TransUnion by 63.7% during the first quarter. Essential Partners LLC now owns 609 shares of the business services provider’s stock worth $42,000 after acquiring an additional 237 shares in the last quarter. Finally, Osterweis Capital Management Inc. bought a new stake in shares of TransUnion during the second quarter worth about $45,000.
About TransUnion
TransUnion is a global information and insights company that helps businesses and consumers make critical decisions using data and analytics. As one of the three major credit bureaus in the United States, TransUnion collects and aggregates credit information on individuals and businesses, providing credit reports, risk scores and portfolio management tools to financial institutions, lenders, landlords and other decision makers. Its consumer-facing products enable individuals to monitor credit status, detect identity theft and access personalized financial insights.
The company’s offerings span credit risk assessment, identity management, fraud prevention and marketing solutions.
Read More
- Five stocks we like better than TransUnion
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?